@article{article, title  = {{The Utility Of Minimal Residual Disease (MRD) Assessment At First Relapse: Results From The BSBMT/Ukmf Myeloma X (Intensive) Trial}},

 publisher = {{American Society of Hematology}},

 url = {{}},

 year = {{2013}},

 month = {{11}},

 author = {{Ashcroft J and de Tute RM and Cairns DA and Fletcher M and Owen RG and Rawstron A and O'Connor SJM and Williams CD and Snowden JA and Cavenagh JD and Parrish C et al}},

 doi = {{10.1182/blood.v122.21.3378.3378}},

 volume = {{122}},

 journal = {{Blood}},

 issue = {{21}},

 pages = {{3378-3378}},

 note = {{Accessed on 2025/04/06}}}